Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2025-03-19 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR DOUBLE-CRANE FOR THE YEAR ENDED 31 DECEMBER 2024
Report Publication Announcement Classification · 75% confidence The document is an HKEX announcement summarizing the principal financial information of a subsidiary’s audited annual report, and directs readers to refer to the full annual report on the Shanghai Stock Exchange website. It is not the full annual report itself, but rather a brief publication announcement of that report. Under our “menu vs meal” rule this is an announcement of the report’s release rather than the report content, so it fits the Report Publication Announcement category (RPA).
2025-03-19 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2024
Report Publication Announcement Classification · 85% confidence The document is a concise announcement (~4,500 characters) summarizing the principal financial information of a subsidiary’s audited annual financials and stating that the full annual report has been released and is available on the Shenzhen Stock Exchange website. It does not contain the full report itself but merely announces its publication and provides key highlights. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2025-03-18 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF DONG-E-E-JIAO FOR THE YEAR ENDED 31 DECEMBER 2024
Report Publication Announcement Classification · 80% confidence The document is a stock exchange announcement by China Resources Pharmaceutical Group Limited summarizing the key audited annual financials of its associate Dong-E-E-Jiao and noting that Dong-E-E-Jiao has released its annual report for the year ended 31 December 2024. It provides high-level figures and a dividend proposal before referring readers to the full report on the Shenzhen Stock Exchange website. It does not itself contain the full annual report of the issuer, nor is it a standalone earnings release, management discussion, or proxy statement. Rather, it announces the publication of an external report and provides summary highlights, fitting the definition of a Report Publication Announcement (RPA).
2025-03-17 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 80% confidence The document is a Hong Kong Exchange announcement summarizing key audited annual financial results of a principal subsidiary (CR Sanjiu) for the year ended 31 December 2024. It provides high‐level revenue, profit, asset and dividend figures – essentially an initial release of annual earnings highlights rather than the full annual report itself. Therefore, it best fits the “Earnings Release” category, which covers the initial announcement of periodical financial results (key highlights only). FY 2024
2025-03-12 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF KPC FOR THE YEAR ENDED 31 DECEMBER 2024
Report Publication Announcement Classification · 85% confidence The document is a short HKEX-style announcement (≈4,110 characters) summarizing key financial information of a subsidiary’s annual report and stating that the full report has been released on the Shanghai Stock Exchange website. It does not contain the full audited annual report itself but merely announces its publication and provides high‐level highlights. Under the “menu vs. meal” rule, this is an announcement of a report’s publication rather than the report itself, so it should be classified as a Report Publication Announcement (RPA).
2025-03-11 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 85% confidence The document is a short Hong Kong Exchange announcement notifying investors of a forthcoming board meeting to consider and approve the annual results and the recommendation of a final dividend. It does not contain the actual results or financial data, nor any voting outcomes or board composition changes. It serves to announce the timing of the publication process for the annual report. Under our taxonomy, this falls under “Report Publication Announcement (RPA)” as it informs stakeholders when the company will publish its annual results rather than providing the report itself.
2025-03-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.